德基科技(01301.HK)與華潤水泥(01313.HK)籤合作框架 擬設商品瀝青混合料生產基地
德基科技(01301.HK)公佈,與華潤水泥(01313.HK)簽訂戰略合作框架協議,就裝備設計製造、商品化瀝青混合料、裝備智能化及香港科研項目及人才培養等方面開展合作。
根據戰略合作框架協議,依託集團生產及運營高端環保瀝青混合料攪拌設備的專業經驗及技術實力,結合華潤水泥在華南和西南地區的業務佈局及行業地位,雙方計劃在區域內建設固定式綠色瀝青混合料生產基地。此外,未來雙方將就混凝土裝備智能化、大型裝備設計及製造技術,以及香港科研項目及人才培養等方面探討進一步合作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.